Zymeworks (ZYME) Share-based Compensation (2021 - 2026)

Zymeworks (ZYME) has 6 years of Share-based Compensation data on file, last reported at $6.9 million in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation rose 806.54% year-over-year to $6.9 million; the trailing twelve-month figure through Mar 2026 stood at $34.2 million (up 4371.11% YoY), and the FY2025 full-year result was $28.0 million, changed N/A from the prior year.
• Share-based Compensation eased to $6.9 million in Q1 2026, from $8.8 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $11.5 million in Q2 2025 to a low of -$8.1 million in Q3 2024.
• A 5-year average of $2.3 million and a median of $2.0 million in 2023 frame the typical range for Share-based Compensation.
• Peak annual rise in Share-based Compensation reached 3129.17% in 2023, while the deepest fall reached 952.61% in 2023.
• Tracing ZYME's Share-based Compensation over 5 years: stood at $555000.0 in 2022, then tumbled by 952.61% to -$4.7 million in 2023, then sank by 71.32% to -$8.1 million in 2024, then soared by 209.16% to $8.8 million in 2025, then slipped by 21.64% to $6.9 million in 2026.
• Business Quant data shows ZYME's Share-based Compensation at $6.9 million in Q1 2026, $8.8 million in Q4 2025, and $6.9 million in Q3 2025.